Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:34 PM
Ignite Modification Date:
2025-12-24 @ 3:34 PM
NCT ID:
NCT01836692
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed NSCLC
* Inoperable Stage III disease (T3N1-3, any T4, any N2 -3) confirmed by PET scanning, mediastinoscopy or thoracoscopy
* Patients treated with at least 2 cycles of platinum based induction chemotherapy and able to start radiotherapy within 5 weeks of the last cycle of chemotherapy
* Tumour judged inoperable by a lung MDT
* Age 18+, no upper age limit
* Performance status (PS) - ECOG 0-2. Patients with PS 2 whose general condition is explained by disease can be included at the discretion of the local investigator. Patients with PS 2 as a result of co-morbid conditions will be excluded
* Patient considered suitable for radical RT
* Tumour that can be encompassed within a radical RT treatment volume (MLD expected to be \<20Gy)
Exclusion Criteria:
* Patients suitable for standard concurrent CTRT
* Patients only suitable for radical RT due to PS and co-morbidities
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01836692
Study Brief:
Protocol Section:
NCT01836692